An overview on d-amino acids

G Genchi - Amino acids, 2017 - Springer
More than half a century ago researchers thought that d-amino acids had a minor function
compared to l-enantiomers in biological processes. Many evidences have shown that d …

Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia

M Carbon, CU Correll - CNS spectrums, 2014 - cambridge.org
Since currently available antipsychotic medications predominantly treat hallucinations,
delusions, disorganized thoughts and behavior, and related agitation/aggression, attention …

[HTML][HTML] Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment

MJ Millan, K Fone, T Steckler, WP Horan - European …, 2014 - Elsevier
Schizophrenia is a complex and multifactorial disorder generally diagnosed in young adults
at the time of the first psychotic episode of delusions and hallucinations. These positive …

The NMDA receptor as a target for cognitive enhancement

GL Collingridge, A Volianskis, N Bannister, G France… - …, 2013 - Elsevier
NMDA receptors (NMDARs) play an important role in neural plasticity including long-term
potentiation and long-term depression, which are likely to explain their importance for …

Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders

K Hashimoto, B Malchow, P Falkai… - European archives of …, 2013 - Springer
Severe psychiatric disorders such as schizophrenia are related to cognitive and negative
symptoms, which often are resistant to current treatment approaches. The glutamatergic …

D-Serine: potential therapeutic agent and/or biomarker in schizophrenia and depression?

MAB MacKay, M Kravtsenyuk, R Thomas… - Frontiers in …, 2019 - frontiersin.org
D-Serine is a potent co-agonist at the NMDA glutamate receptor and has been the object of
many preclinical studies to ascertain the nature of its metabolism, its regional and cellular …

Involvement of cholinergic, adrenergic, and glutamatergic network modulation with cognitive dysfunction in Alzheimer's disease

YJ Cheng, CH Lin, HY Lane - International Journal of Molecular Sciences, 2021 - mdpi.com
Alzheimer's disease (AD), the most common cause of dementia, is a progressive
neurodegenerative disease. The number of AD cases has been rapidly growing worldwide …

d-AMINO ACIDS IN ANIMAL PEPTIDES

G Kreil - Annual review of biochemistry, 1997 - annualreviews.org
d-amino acids have been detected in a variety of peptides synthesized by animal cells.
These include opiate and antimicrobial peptides from amphibian skin, neuropeptides from …

Glutamatergic transmission in schizophrenia: from basic research to clinical practice

J Kantrowitz, DC Javitt - Current opinion in psychiatry, 2012 - journals.lww.com
Glutamatergic transmission in schizophrenia: from basic rese... : Current Opinion in Psychiatry
Glutamatergic transmission in schizophrenia: from basic research to clinical practice : Current …

Targeting of NMDA receptors in new treatments for schizophrenia

K Hashimoto - Expert opinion on therapeutic targets, 2014 - Taylor & Francis
Introduction: Abnormalities in glutamatergic neurotransmission mediated by N-methyl-d-
aspartate (NMDA) are implicated in the pathophysiology of schizophrenia, although the …